[HTML] springer.com

[HTML][HTML] Unlocking the value of anti-TNF biosimilars: reducing disease burden and improving outcomes in chronic immune-mediated inflammatory diseases: a …

MF Rezk, B Pieper - Advances in therapy, 2020 - Springer
Immune-mediated inflammatory diseases (IMIDs) are chronic conditions that create a
significant disease burden on millions of patients while adding a major financial burden to …
被引用次数：15 相关文章

Unlocking the Value of Anti-TNF Biosimilars: Reducing Disease Burden and Improving Outcomes in Chronic Immune-Mediated Inflammatory Diseases: A Narrative …

MF Rezk, B Pieper - Advances in Therapy, 2020 - europepmc.org
Unlocking the Value of Anti-TNF Biosimilars: Reducing Disease Burden and Improving
Outcomes in Chronic Immune-Mediated Inflammatory Diseases: A Narrative Review. - Abstract …
[PDF] archive.org

[PDF][PDF] Unlocking the Value of Anti-TNF Biosimilars: Reducing Disease Burden and Improving Outcomes in Chronic Immune-Mediated Inflammatory Diseases: A …

MFRB Pieper - Adv Ther, 2020 - scholar.archive.org
Immune-mediated inflammatory diseases (IMIDs) are chronic conditions that create a
significant disease burden on millions of patients while adding a major financial burden to …
[HTML] nih.gov

[HTML][HTML] Unlocking the Value of Anti-TNF Biosimilars: Reducing Disease Burden and Improving Outcomes in Chronic Immune-Mediated Inflammatory Diseases: A …

MF Rezk, B Pieper - Advances in Therapy, 2020 - ncbi.nlm.nih.gov
Unlocking the Value of Anti-TNF Biosimilars: Reducing Disease Burden and Improving
Outcomes in Chronic Immune-Mediated Inflammatory Diseases: A Narrative Review - PMC …

Unlocking the Value of Anti-TNF Biosimilars: Reducing Disease Burden and Improving Outcomes in Chronic Immune-Mediated Inflammatory Diseases: A Narrative …

MF Rezk, B Pieper - Advances in therapy, 2020 - pubmed.ncbi.nlm.nih.gov
Immune-mediated inflammatory diseases (IMIDs) are chronic conditions that create a
significant disease burden on millions of patients while adding a major financial burden to …